288 related articles for article (PubMed ID: 8381832)
1. Peptide-priming of cytolytic T cell immunity in vivo using beta 2-microglobulin as an adjuvant.
Rock KL; Fleischacker C; Gamble S
J Immunol; 1993 Feb; 150(4):1244-52. PubMed ID: 8381832
[TBL] [Abstract][Full Text] [Related]
2. IFN-gamma-induced recognition of the antigen-processing variant CMT.64 by cytolytic T cells can be replaced by sequential addition of beta 2 microglobulin and antigenic peptides.
Jefferies WA; Kolaitis G; Gabathuler R
J Immunol; 1993 Sep; 151(6):2974-85. PubMed ID: 8397249
[TBL] [Abstract][Full Text] [Related]
3. Induction of class I MHC-restricted, peptide-specific cytolytic T lymphocytes by peptide priming in vivo.
Ishioka GY; Colon S; Miles C; Grey HM; Chesnut RW
J Immunol; 1989 Aug; 143(4):1094-100. PubMed ID: 2787356
[TBL] [Abstract][Full Text] [Related]
4. Peptide loading of empty major histocompatibility complex molecules on RMA-S cells allows the induction of primary cytotoxic T lymphocyte responses.
De Bruijn ML; Schumacher TN; Nieland JD; Ploegh HL; Kast WM; Melief CJ
Eur J Immunol; 1991 Dec; 21(12):2963-70. PubMed ID: 1660811
[TBL] [Abstract][Full Text] [Related]
5. Ovalbumin injected with complete Freund's adjuvant stimulates cytolytic responses.
Ke Y; Li Y; Kapp JA
Eur J Immunol; 1995 Feb; 25(2):549-53. PubMed ID: 7875219
[TBL] [Abstract][Full Text] [Related]
6. Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif.
Lipford GB; Hoffman M; Wagner H; Heeg K
J Immunol; 1993 Feb; 150(4):1212-22. PubMed ID: 7679422
[TBL] [Abstract][Full Text] [Related]
7. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product.
Guimezanes A; Schumacher TN; Ploegh HL; Schmitt-Verhulst AM
Eur J Immunol; 1992 Jun; 22(6):1651-4. PubMed ID: 1318201
[TBL] [Abstract][Full Text] [Related]
8. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
Zügel U; Schoel B; Kaufmann SH
J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
[TBL] [Abstract][Full Text] [Related]
9. V beta 5+ T cell receptors skew toward OVA+H-2Kb recognition.
Dillon SR; Jameson SC; Fink PJ
J Immunol; 1994 Feb; 152(4):1790-801. PubMed ID: 8120388
[TBL] [Abstract][Full Text] [Related]
10. Immunization with soluble hepatitis B virus surface protein elicits murine H-2 class I-restricted CD8+ cytotoxic T lymphocyte responses in vivo.
Schirmbeck R; Melber K; Kuhröber A; Janowicz ZA; Reimann J
J Immunol; 1994 Feb; 152(3):1110-9. PubMed ID: 8301120
[TBL] [Abstract][Full Text] [Related]
11. Class I-restricted presentation occurs without internalization or processing of exogenous antigenic peptides.
Hosken NA; Bevan MJ; Carbone FR
J Immunol; 1989 Feb; 142(4):1079-83. PubMed ID: 2492575
[TBL] [Abstract][Full Text] [Related]
12. In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells.
Bellone M; Iezzi G; Manfredi AA; Protti MP; Dellabona P; Casorati G; Rugarli C
Eur J Immunol; 1994 Nov; 24(11):2691-8. PubMed ID: 7525300
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus class I-restricted peptide induces cytotoxic T lymphocytes in vivo independent of CD4+ T cells.
Vasilakos JP; Michael JG
J Immunol; 1993 Mar; 150(6):2346-55. PubMed ID: 8095512
[TBL] [Abstract][Full Text] [Related]
14. Creating CTL targets with epitope-linked beta 2-microglobulin constructs.
Uger RA; Barber BH
J Immunol; 1998 Feb; 160(4):1598-605. PubMed ID: 9469415
[TBL] [Abstract][Full Text] [Related]
15. Induction of CTL in vivo by major histocompatibility complex class I-peptide complexes covalently associated on the cell surface.
Anjuère F; Horvath C; Cerottini JC; Luescher IF
Eur J Immunol; 1995 Jun; 25(6):1535-40. PubMed ID: 7614979
[TBL] [Abstract][Full Text] [Related]
16. The Q7 alpha 3 domain alters T cell recognition of class I antigens.
Aldrich CJ; Lowen LC; Mann D; Nishimura M; Hood L; Stroynowski I; Forman J
J Immunol; 1991 May; 146(9):3082-90. PubMed ID: 1849941
[TBL] [Abstract][Full Text] [Related]
17. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
Wild J; Grusby MJ; Schirmbeck R; Reimann J
J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
[TBL] [Abstract][Full Text] [Related]
18. Immunization of mice with the N-terminal (1-272) fragment of simian virus 40 large T antigen (without adjuvants) specifically primes cytotoxic T lymphocytes.
Schirmbeck R; Zerrahn J; Kuhröber A; Deppert W; Reimann J
Eur J Immunol; 1993 Jul; 23(7):1528-34. PubMed ID: 8325328
[TBL] [Abstract][Full Text] [Related]
19. The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen.
Milligan GN; Morrison LA; Gorka J; Braciale VL; Braciale TJ
J Immunol; 1990 Nov; 145(10):3188-93. PubMed ID: 1700000
[TBL] [Abstract][Full Text] [Related]
20. Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses.
Newman MJ; Wu JY; Gardner BH; Munroe KJ; Leombruno D; Recchia J; Kensil CR; Coughlin RT
J Immunol; 1992 Apr; 148(8):2357-62. PubMed ID: 1373166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
